passage analysis macbeth act 1 scene 5
Tài liệu Báo cáo Y học: NMR-based determination of the binding epitope and conformational analysis of MUC-1 glycopeptides and peptides bound to the breast cancer-selective monoclonal antibody SM3 pptx
Ngày tải lên :
21/02/2014, 15:20
... 2.397 1. 983 1. 983 1. 983 3.368 3. 317
Asp9 – 4.779 2.747 2 .55 8
Thr10 8. 914 4.4 45 4.297 1. 217
Arg 11 8. 51 0 4 .50 4 1. 813 1. 678 1. 6 45 1. 6 45 3 .16 0 3 .16 0
Pro12 4.2 95 2.270 1. 990 1. 990 1. 879 3.7 05 3 .5 91
CONH ... 2.389 1. 978 1. 978 1. 978 3.336 3.336
Asp9 4.666 2.707 2 .54 3
Thr10 8.386 4. 252 4 . 15 5 1. 134
Arg 11 8.484 4 .57 4 1. 798 1. 724 1. 629 1. 629 3 .16 0 3 .16 0
Pro12 4.327 2. 255 1. 978 1. 978 1. 879 3.782 3 .58 2
CONH ... 7.788
CONHÂ 7. 017
NHCH 312 3 456 a6b
GalNAc 7.803 1. 9 75 4.7 75 4. 016 3. 850 3. 914 3.972 3. 7 15 3.6 91
1446 H. Mo
ă
ller et al. (Eur. J. Biochem. 269) Ó FEBS 2002
site of SM3 is shown in Fig. 5B. For comparison...
- 12
- 717
- 0
Báo cáo khoa học: Dual expression of mouse and rat VRL-1 in the dorsal root ganglion derived cell line F-11 and biochemical analysis of VRL-1 after heterologous expression pptx
Ngày tải lên :
31/03/2014, 07:20
... VRL -1/ 1061F: 5 -ACTCGGTGC
TGGAGATCATC-3Â and VRL -1/ 1897R: 5 -TGAGAAG
GACGTAGGCCAAC-3Â to obtain fragment C with
836 bp; rVRL -11 618 F: 5 -TTCCTGCTGGTCTACCTG
GT-3Â and rVRL -12 251 R: 5 -CTTCCTCTGAGGCACT
GTTC-3Â ... after
reverse transcription of F -11 total RNA (fragment A: 34
56 8 bp ẳ 53 4 bp, fragment B: 54 912 05 bp ẳ 656 bp,
fragment C: 10 611 897 bp ẳ 836 bp and fragment D:
16 1 818 97 bp ẳ 633 bp). Even though ... rVRL - 15 68R: 5 -CATCCGCTCCATTCTCTACC-3Â
to obtain fragment A with 53 4 bp; rVRL - 15 49F:
5 -GGTAGAGAATGGAGCGGATG-3Â and rVRL -1
1205R: 5 -ACCAAGTAGCAGGCGAAGTT-3Â to obtain
fragment B with 656 bp; VRL -1/ 1061F:...
- 8
- 439
- 0
Advances in Vibration Analysis Research Part 1 doc
Ngày tải lên :
20/06/2014, 00:20
... 7.06 858 2 75 7.06 858 2 75 7.06 858 2 75
3 10 . 210 176 10 . 210 17 612 10 . 210 17 612 10 . 210 17 612
C-F
1 1.87 51 0 4 1. 87 51 0 407 1. 87 51 0 407 1. 87 51 0 407
2 4.6940 91 4.6940 911 3 4.6940 911 3 4.6940 911 3
3 7. 854 757 7. 854 757 44 ... 1. 96344 51 2
2 4 .58 876 313 4 .58 876 313 4 .58 876 313
3 7 .52 5 312 08 7 .52 5 312 08 7 .52 5 312 08
C-S
1 2. 355 00726 2. 355 00726 2. 355 00726
2 5. 2 612 5 51 1 5. 2 612 5 51 1 5. 2 612 5 51 1
3 8. 217 83948 8. 217 83948 8. 217 83948
... Exact ADM VIM HPM
P-P
1
3 .14 159 2 65 (
π
)
3 .14 159 2 65 3 .14 159 2 65 3 .14 159 2 65
2
6.28 318 5 31 (2
π
)
6.28 318 5 31 6.28 318 5 31 6.28 318 5 31
3
9.42477796 (3
π
)
9.42477796 9.4247796 9.4247796
C-C
1...
- 30
- 344
- 0
báo cáo hóa học:" The HIV-1 Non-subtype B Workgroup: An International Collaboration for the Collection and Analysis of HIV-1 Non-subtype B Data" pot
Ngày tải lên :
20/06/2014, 08:20
... transcriptase inhibi-
tors. AIDS 2003, 17 :F1-F5. Abstract
15 . Kantor R, Shafer RW, Efron B, et al.: HIV -1 subtype-related differ-
ences in genotypic evolution: analysis of subtypes B and C
reverse ... et al.: Drug resistance
mutations in HIV -1. Top HIV Med 2003, 11 :92-96. Abstract
11 . Shafer RW, Jung DR, Betts BJ: Human immunodeficiency virus
type 1 reverse transcriptase and protease mutation ... protease sequences. Program and
abstracts of the 11 th Conference on Retroviruses and Opportunistic Infec-
tions; February 811 , 2004; San Francisco, California . Abstract 59
...
- 3
- 332
- 0
Báo cáo y học: "Genetic analysis of HIV-1 Circulating Recombinant Form 02_AG, B and C subtype-specific envelope sequences from Northern India and their predicted co-receptor usage" pot
Ngày tải lên :
10/08/2014, 05:21
... sequences.
1, ,*7% ,1& apos; 1& apos;)-
1, ,*7% ,1& apos; 1& apos;)-
1, ,*7% ,1& apos; 1& apos;)-
1, ,*7% ,1& apos; 1& apos;)-
$* 1( 1( $-
1, ,*7% ,1& apos; 1& apos;)-
$*6( 61 $-
1, ,3*, ,1& apos;&)-
$*''% 61 $)
$*'' 61 $)
5HI$$836'D\'4
5HI$.(4$)
5HI$* 1* [, %1* /
5HI$*&0S%'$<
5HI+%(9,$)
5HI+%(9,$)
5HI$(7+&08
5HI$(7+7+$%
5HI*%(&apos ;5& amp;%/$)
5HI-&'-'&.7%()
5HI-6(6($)
5HI*.(++$)
5HI$&'&'.7%$)
5HI$&<&<$)
5HI)%(9,$)
5HI% )5 +;%/$,,,,% %58 .
1, ,3*, ,1& apos;97)-
5HI% 1/ 7$<
5HI) %5 %5 $)
5HI'&0&0+$/$<
5HI.&'(47%&$-
5HI.&003$-
1, ,3*, ,1& apos;()-
1, ,3*, ,1& apos;')-
5HI& %5 %5 G8
5HI&(7(7+8
5HI& ,1 ,1 $)
1, ,3*, ,1& apos;$)-
1, ,3*, ,1& apos;()-
1, ,3*, ,1& apos;')-
1, ,3*, ,1& apos;$)-
5HI'&'(/,.
5HI2 61 6(03$-
c
n
o
d
6XEW\SH&
6XEW\SH%
& ;5) B$*
... sequences.
1, ,*7% ,1& apos; 1& apos;)-
1, ,*7% ,1& apos; 1& apos;)-
1, ,*7% ,1& apos; 1& apos;)-
1, ,*7% ,1& apos; 1& apos;)-
$* 1( 1( $-
1, ,*7% ,1& apos; 1& apos;)-
$*6( 61 $-
1, ,3*, ,1& apos;&)-
$*''% 61 $)
$*'' 61 $)
5HI$$836'D\'4
5HI$.(4$)
5HI$* 1* [, %1* /
5HI$*&0S%'$<
5HI+%(9,$)
5HI+%(9,$)
5HI$(7+&08
5HI$(7+7+$%
5HI*%(&apos ;5& amp;%/$)
5HI-&'-'&.7%()
5HI-6(6($)
5HI*.(++$)
5HI$&'&'.7%$)
5HI$&<&<$)
5HI)%(9,$)
5HI% )5 +;%/$,,,,% %58 .
1, ,3*, ,1& apos;97)-
5HI% 1/ 7$<
5HI) %5 %5 $)
5HI'&0&0+$/$<
5HI.&'(47%&$-
5HI.&003$-
1, ,3*, ,1& apos;()-
1, ,3*, ,1& apos;')-
5HI& %5 %5 G8
5HI&(7(7+8
5HI& ,1 ,1 $)
1, ,3*, ,1& apos;$)-
1, ,3*, ,1& apos;()-
1, ,3*, ,1& apos;')-
1, ,3*, ,1& apos;$)-
5HI'&'(/,.
5HI2 61 6(03$-
c
n
o
d
6XEW\SH&
6XEW\SH%
& ;5) B$*
... sequences.
1, ,*7% ,1& apos; 1& apos;)-
1, ,*7% ,1& apos; 1& apos;)-
1, ,*7% ,1& apos; 1& apos;)-
1, ,*7% ,1& apos; 1& apos;)-
$* 1( 1( $-
1, ,*7% ,1& apos; 1& apos;)-
$*6( 61 $-
1, ,3*, ,1& apos;&)-
$*''% 61 $)
$*'' 61 $)
5HI$$836'D\'4
5HI$.(4$)
5HI$* 1* [, %1* /
5HI$*&0S%'$<
5HI+%(9,$)
5HI+%(9,$)
5HI$(7+&08
5HI$(7+7+$%
5HI*%(&apos ;5& amp;%/$)
5HI-&'-'&.7%()
5HI-6(6($)
5HI*.(++$)
5HI$&'&'.7%$)
5HI$&<&<$)
5HI)%(9,$)
5HI% )5 +;%/$,,,,% %58 .
1, ,3*, ,1& apos;97)-
5HI% 1/ 7$<
5HI) %5 %5 $)
5HI'&0&0+$/$<
5HI.&'(47%&$-
5HI.&003$-
1, ,3*, ,1& apos;()-
1, ,3*, ,1& apos;')-
5HI& %5 %5 G8
5HI&(7(7+8
5HI& ,1 ,1 $)
1, ,3*, ,1& apos;$)-
1, ,3*, ,1& apos;()-
1, ,3*, ,1& apos;')-
1, ,3*, ,1& apos;$)-
5HI'&'(/,.
5HI2 61 6(03$-
c
n
o
d
6XEW\SH&
6XEW\SH%
& ;5) B$*
...
- 6
- 417
- 0
Báo cáo y học: " Genetic and functional analysis of HIV-1 Rev Responsive Element (RRE) sequences from North-India" pdf
Ngày tải lên :
10/08/2014, 05:21
... Virol 2008, 15 3 :19 61- 1966.
11 . Husain S, Goila R, Shahi S, Banerjea AC: First report of a healthy Indian
heterozygous for Δ32 mutant of HIV -1 coreceptor-CCR5 gene. Gene 19 98,
207 :14 1 -14 7.
12 . Novitsky ... HIV -1 rev
peptide-RRE RNA complex. Science 19 96, 273 : 15 47 - 15 51 .
5. Plavec I, Agarwal M, Ho KE, Pineda M, Auten J, Baker J, Matsuzaki H,
Escaich S, Bonyhadi M, Bohnlein E: High transdominant RevM10 ... Virol 19 86, 59 :284-2 91.
16 . Malim MH, Cullen BR: HIV -1 structural gene expression requires the
binding of multiple Rev monomers to the viral RRE: Implications for HIV-
1 latency. Cell 19 91, 65: 2 41- 248.
17 ....
- 8
- 406
- 0
HANDBOOK OF SCALING METHODS IN AQUATIC ECOLOGY MEASUREMENT, ANALYSIS, SIMULATION - PART 1 pptx
Ngày tải lên :
11/08/2014, 20:21
... (m)
0
5
10
15
20
20 .5 21 21. 5 22 22 .5
0 5 10 15
Depth (m)
0
5
10
15
20
20 .5 21 21. 5 22 22 .5
0 5 10 15
Depth (m)
0
5
10
15
20
20 .5 21 21. 5 22 22 .5
0 5 10 15
Depth (m)
0
5
10
15
20
20 .5 21 21. 5 22 22 .5
0 5 10 15
Depth ... velocity.
21. 870
20 June 19 98
2029 hrs
A
21. 873
20 June 19 98
210 1 hrs
B
21. 867
20 June 19 98
2248 hrs
C
21. 860
21 June 19 98
013 1 hrs
D
21. 862
21 June 19 98
0 51 1 hrs
E
21. 879
21 June 19 98
0900 hrs
F
20 .5 ... 15
Depth (m)
0
5
10
15
20
20 .5 21 21. 5 22 22 .5
0 5 10 15
Depth (m)
0
5
10
15
20
Sigma-t Sigma-t Sigma-t
Sigma-t Sigma-t Sigma-t
0
2
4
6
8
C
20 June 19 98
2248 hrs
A
B
21 21. 5 22 22 .5
Chlorophyll...
- 76
- 686
- 0
Polyme Analysis 2010 Part 1 pdf
Ngày tải lên :
12/08/2014, 01:22
... of polymer science dealing with analysis and characterisation of
polymers.
üThe complication of macromolecular chains, the dispersion in molecular
weight, tacticity, crystallinity, orientation, ... morphological systems
⇒ analysis of polymer ≠ the small organic materials
⇒ Focus on viscoelasticproperties, dynamic mechanical testing.
Polymer analysis
üThe most important factor is that the tests ... KHOA ĐÀNẴNG
KHOA HOÁ
PHÂN TÍCH POLYME
(POLYMER ANALYSIS)
TS. ĐoànThị Thu Loan
♣♣♣
üNondestructive methods are advantageous and indeed essential when
10 0% of the output is being tested.
üThe tests...
- 9
- 174
- 0
Mechanics Analysis 2010 Part 1 pdf
Ngày tải lên :
12/08/2014, 03:20
...
1. 8 -1. 85 80 .5
19 -19 .3 21. 1
10 .2 21. 5
1. 2 -1. 3 7 .5
1. 2 -1. 35 5.8
1. 2 -1. 3 5. 8
1. 35 -1. 4 3.7
1. 3 -1. 43 8 .5
1. 2 6.7
0. 95
4.7
1. 05 4.3
2.3 1. 5
1. 14 7.0
1. 32 4 .5
1. 24 5. 6
I
.42 13 .4
1. 3 ...
15 -20
15 -30
10 -50
15 -40
75
10 -20
25
5 -1 5
15
4
-
0.2
I60
55 0
58 0
54 0
17 0
250
18 0
IO0
400
17 50
270
56 0
17 00
23
36
22
28
5. 9
5. 5
9
6
13
12 .7
16 0
1. 5
0.8
1. 5 ...
260-700
10 00 -12 00
260
620
400 -50 0
15 0M400
290
14 00-
1
50 0
11 00 -14 50
3300-4000
18 00-2200
6&90
30-70
40-70
25- 50
55 -1
10
80
20- 45
354 5
15 - 35
80
60
70
90 -19 0
9& ;10 0
80...
- 31
- 168
- 0
Báo cáo y học: ":The expression of the receptor for advanced glycation end-products (RAGE) in RA-FLS is induced by IL-17 via Act-1" ppsx
Ngày tải lên :
12/08/2014, 17:22
... Therapy 2 011 , 13 :R 113
http://arthritis-research.com/content /13 /4/R 113
Page 11 of 12
Received: 4 October 2 010 Revised: 3 May 2 011 Accepted: 12 July 2 011
Published: 12 July 2 011
References
1. Schmidt ... 2 011 , 13 :R 113
http://arthritis-research.com/content /13 /4/R 113
Page 12 of 12
Figure 3 IL -17 and IL-1b increased RAGE mRNA expression in RA-FLS.(a) RA-FLS were cultured with 10 ng/ml IL -17 , 5 ... < 0. 05, **P < 0.0 05 compared to IL -17 or inhibitor-treated cells.
Heo et al. Arthritis Research & Therapy 2 011 , 13 :R 113
http://arthritis-research.com/content /13 /4/R 113
Page 9 of 12
Figure...
- 12
- 343
- 0
Báo cáo y học: " Comparative biochemical analysis of HIV-1 subtype B and C integrase enzymes" pot
Ngày tải lên :
12/08/2014, 23:22
... experiments.
0
25
50
75
10 0
12 5
15 0
17 5
Integrase subtype B
Integrase subtype C
n = 5+ /- SEM
0.
00 01
0.0 01
0
. 01
0 .1
1
10
10 0
10 0
0
MK2048 concentration ( M)
Relativ e Strand Transfer Activity (%)
Table ... quantification and analyses
of at least 3 independent experiments.
0
25
50
75
10 0
12 5
15 0
17 5
Integrase subtype C
0.
00 01
0.0 01
0. 01
0 .1
1
10
10 0
10 00
n = 6 +/- SEM
Integrase subtype B
EVG concentration [ ... C
RAL(μM) 1. 71( 0.7-4 .5) 1. 75( 0.7-3.9) 0.37(0.2-0.8) 0 . 15 (0.09-0.3)
MK-2048(μM) 0 .58 (0.28 -1. 20) 0 .19 (0.09-0.39) 0.0 75( 0.04-0 .14 ) 0.08(0.03-0.2)
EVG(μM) 2.66 (1. 44-4. 91) 1. 5( 0.29-7.74) 0. 014 (0.003-0.07)...
- 10
- 282
- 0
Báo cáo y học: "Biophysical analysis of HTLV-1 particles reveals novel insights into particle morphology and Gag stoichiometry" pdf
Ngày tải lên :
13/08/2014, 01:20
... (ms
-1
)
50
10 0
15 0
200
250
Time (s)
0
200
400
600 800 10 00
B
Photon counts (k)
5
10 15
20
0
p(k)
10
0
10
-2
10
-4
10
-6
10
-8
Res
2
0
-2
-4
C
G( )
(ms)
0
1
2
3
4
-1
0. 01
0 .10
1
10 10 0
10 00 010 00
Figure ... 7: 75
http://www.retrovirology.com/content/7 /1/ 75
Page 11 of 13
30
40
50
60
70
80
90
10 0
11 0
12 0
13 0
14 0
15 0
16 0
17 0
18 0
0
10
20
30
VLP diameter (nm)
Frequency
n =17 34
Mean= 71 ± 20 nm
A
(%)
B
Figure 3 Cryo-TEM analysis of HTLV -1 Gag-based ... were then ultracentrifuged at 35, 000 rpm for
30 min at 4°C using a SW 55 Ti rotor. The VLP fraction
was extracted and pelleted at 35, 000 rpm, 4°C for 1. 5 hr
using a SW 55 Ti rotor (Beckman). After...
- 13
- 235
- 0
